The Critical Side Effect Doctors Aren't Discussing: Out-of-Pocket Costs
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
How is a physician supposed to know which medicine is most affordable under which insurance plan?
Fortunately, there are tools coming into use designed to help clinicians figure out patient-specific costs of any medication they prescribe. The tools (jargon alert!) are called RTBTs, for real-time benefit tools.

Paul Kostick’s DNA was under attack and his fate was sealed. Forces beyond his control were hacking large pieces of genetic material off the ends of his chromosomes. Should his doctor tell him how long he has to live?
When Rita Volk, a busy college student, first experienced a nagging sensation in her right ear, she ignored it. Even though she felt like she was traveling in an under-pressurized airplane, Volk assumed the problem would go away. But it persisted, and her primary care doctor recommended she see an ear, nose and throat (ENT)…
In the April issue of Health Affairs, a group of authors explored the cost-containment strategies and four “high income countries“, and try to see what they were doing that we are currently not doing in the United States. The first picture below, shows all five countries and reveals that, over the last 10 years, only…
NPR’s Planet Money published two excellent graphs this week, comparing health care spending in the US now versus the 70s and 90s. For example, here’s what they reveal about hospital versus non-hospital spending: In other words, hospitals have a shrinking proportion of the health care dollar, but not one that is shrinking very much. Despite…
For years now, the pharmaceutical industry has justified its prices and its profits by reminding us that their products eventually go off patent, and are then offered cheaply to people around the world in generic form. They warned us that the pipeline for new and innovative drugs is less and less promising, because so many…